首页> 外文期刊>Antimicrobial agents and chemotherapy. >Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.
【24h】

Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.

机译:全国范围内对法国头孢他啶耐药铜绿假单胞菌菌株产生的广谱β-内酰胺酶,金属β-内酰胺酶和广谱草酸酶的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

A nationwide study aimed to identify the extended-spectrum beta-lactamases (ESBLs), metallo-beta-lactamases (MBLs), and extended-spectrum oxacillinases (ES-OXAs) in a French collection of 140 clinical Pseudomonas aeruginosa isolates highly resistant to ceftazidime. Six ESBLs (PER-1, n=3; SHV-2a, n=2; VEB-1a, n=1), four MBLs (VIM-2, n=3; IMP-18, n=1), and five ES-OXAs (OXA-19, n=4; OXA-28, n=1) were identified in 13 isolates (9.3% of the collection). The prevalence of these enzymes is still low in French clinical P. aeruginosa isolates but deserves to be closely monitored.
机译:一项全国性研究旨在在法国收集的140株对头孢他啶具有高度耐药性的临床铜绿假单胞菌菌株中鉴定出广谱β-内酰胺酶(ESBL),金属β-内酰胺酶(MBL)和广谱草酸酶(ES-OXA) 。六个ESBL(PER-1,n = 3; SHV-2a,n = 2; VEB-1a,n = 1),四个MBL(VIM-2,n = 3; IMP-18,n = 1)和五个在13个分离株(占集合的9.3%)中鉴定了ES-OXA(OXA-19,n = 4; OXA-28,n = 1)。在法国临床的铜绿假单胞菌分离物中,这些酶的流行率仍然很低,但值得密切监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号